Mansour Tobaiqy
Assessment of tigecycline prescription and patients' outcomes at three different hospitals in Saudi Arabia.
Tobaiqy, Mansour; Al Humaid, Saad; Stewart, Derek; Alotaibi, Fayez Omear; Qureshi, Kamal Ahmad; MacLure, Katie; Algharib, Fahad; Alsameti, Ahmed; Alsaqer, Ahmed; Almeman, Ahmad
Authors
Saad Al Humaid
Derek Stewart
Fayez Omear Alotaibi
Kamal Ahmad Qureshi
Katie MacLure
Fahad Algharib
Ahmed Alsameti
Ahmed Alsaqer
Ahmad Almeman
Abstract
The purpose of this study is to investigate tigecycline prescription and patient outcomes in the Kingdom of Saudi Arabia (KSA). A retrospective observational study was conducted in three KSA government hospitals, between January, 2013 and May, 2014. The patients were identified from electronic prescription records; data were retrieved by trained researchers. Thirty-seven patients who received tigecycline were included (mean age, 52.5 years; range, 17 92); 51.4 % were female. Tigecycline was prescribed for sepsis (59.5 %), pneumonia (21.6 %), and/or intra-abdominal infections (13.5 %). The majority of the patients (86.5 %) were prescribed tigecycline in intensive care unit (ICU) and the remaining patients were in the general medical ward. APCHE II score at the beginning of treatment was 16.8 ± 4.3, indicating severe disease. Susceptibility testing revealed 22 different bacterial pathogens, most commonly Acinetobacter baumannii (20 patients) and Klebsiella pneumoniae (14 patients). A significant proportion (56.7 %) was polymicrobial and 16.2 % involved suspected resistant pathogens. Sixteen patients recovered (5 on tigecycline alone, 5 with additional antimicrobials, and six switched to alternatives) while 21 patients died (nine on tigecycline alone, 12 with additional antimicrobials). The study revealed that tigecycline prescription was conducted according to marketing authorizations and national guidelines. Infection severity/stage and comorbidities may influence patients’ response, and explain some of the poor outcomes.
Citation
TOBAIQY, M., AL HUMAID, S., STEWART, D., ALOTAIBI, F.O., QURESHI, K.A., MACLURE, K., ALGHARIB, F., ALSMETI, A., ALSAQER, A. and ALMEMAN, A. 2015. Assessment of tigecycline prescription and patients' outcomes at three different hospitals in Saudi Arabia. Tropical journal of pharmaceutical research [online], 14(10), pages 1919-1926. Available from: https://doi.org/10.4314/tjpr.v14i10.26
Journal Article Type | Article |
---|---|
Acceptance Date | Sep 6, 2015 |
Online Publication Date | Oct 31, 2015 |
Publication Date | Oct 31, 2015 |
Deposit Date | Jun 1, 2016 |
Publicly Available Date | Nov 1, 2016 |
Journal | Tropical journal of pharmaceutical research |
Print ISSN | 1596-5996 |
Electronic ISSN | 1596-9827 |
Publisher | Pharmaceutical Group |
Peer Reviewed | Peer Reviewed |
Volume | 14 |
Issue | 10 |
Pages | 1919-1926 |
DOI | https://doi.org/10.4314/tjpr.v14i10.26 |
Keywords | Kingdom of Saudi Arabia; Prescription patterns; Mortality; Tigecycline; Antimicrobial |
Public URL | http://hdl.handle.net/10059/1499 |
Contract Date | Jun 1, 2016 |
Files
TOBAIQY 2015 Assessment of Tigecycline
(249 Kb)
PDF
Publisher Licence URL
https://creativecommons.org/licenses/by-nc-nd/4.0/
Downloadable Citations
About OpenAIR@RGU
Administrator e-mail: publications@rgu.ac.uk
This application uses the following open-source libraries:
SheetJS Community Edition
Apache License Version 2.0 (http://www.apache.org/licenses/)
PDF.js
Apache License Version 2.0 (http://www.apache.org/licenses/)
Font Awesome
SIL OFL 1.1 (http://scripts.sil.org/OFL)
MIT License (http://opensource.org/licenses/mit-license.html)
CC BY 3.0 ( http://creativecommons.org/licenses/by/3.0/)
Powered by Worktribe © 2025
Advanced Search